David M. Goldstein, Chief Scientific Officer at Principia Biopharma Inc. (PRNB), sold 12,000 shares at $60.39 ($722K) on 2020-05-07, disclosed to the SEC on 2020-05-08.
Open-market sale of $722k PRNB by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.96 | 3,281 | $197K | 27.3% |
| 2 | $59.96 | 3,281 | $197K | 27.3% |
| 3 | $60.39 | 2,719 | $164K | 22.7% |
| 4 | $60.39 | 2,719 | $164K | 22.7% |
| Total | $60.15 avg | 12,000 | $722K | 100% |
| Filing → |